Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Is it possible to achieve a target of zero central line associated bloodstream infections?

Worth, Leon J.a; McLaws, Mary-Louiseb,c

Current Opinion in Infectious Diseases: December 2012 - Volume 25 - Issue 6 - p 650–657
doi: 10.1097/QCO.0b013e32835a0d1a
ANTIMICROBIAL AGENTS: Edited by Monica A. Slavin, Simon L. Croft and Deenan Pillay
Buy

Purpose of review Central venous catheter (CVC)-associated bloodstream infections (CLABSIs) result in poorer patient outcomes and increased healthcare costs. Reduced reimbursement for CLABSI events is now provided for hospitalized patients in the United States. Although a zero target is proposed, the feasibility has not been evaluated. The objective of this review is to identify factors contributing to CLABSI and determine whether current evidence supports attainment of a zero infection rate.

Recent findings Limitations of current surveillance methods and reporting of aggregate data impact on achieving target CLABSI rates. Standard prevention practices, including physician and patient preparation (e.g. hand hygiene), are frequently incorporated into bundles of care. CVC dwell time has been identified as means of risk stratification. Additional strategies (e.g. chlorhexidine-impregnated dressings, antimicrobial-coated devices) may be better used in patients with expected long dwell times. Non-ICU populations are increasingly targeted with prevention strategies, but expected rates of infection have not been proposed.

Summary A zero CLABSI rate should be the target only for ICU populations having CVCs with a dwell time of 1–9 days following aseptic insertion. Additional measures should be reserved for patients with expected longer dwell time. Refinement and validation of surveillance methodology is required before target CLABSI rates can be proposed for non-ICU populations.

aPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia

bSchool of Public Health and Community Medicine, Faculty of Medicine, The University of New South Wales

cClinical Excellence Commission, Sydney, New South Wales, Australia

Correspondence to Dr Leon J. Worth, Peter MacCallum Cancer Centre, Locked Bag 1 A’Beckett Street, Melbourne, VIC 8006, Australia.Tel: +61 9656 5853; fax: +61 9656 1185; e-mail: leon.worth@petermac.org

© 2012 Lippincott Williams & Wilkins, Inc.